ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q4 2020 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (ACOR) Q4 2020 Earnings Conference Call March 4, 2021 4:30 P.M. ET Company Participants Tierney Saccavino - Executive Vice President and Corporate Communications Ron Cohen - Chief Executive Officer Conference Call Participants Presentation Operator Welcome to Acorda Therapeutics Fourth Quarter and Year-End 2020 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised, that this call is being recorded at the company's request. I will now introduce your host for today's call, Ms. Tierney Saccavino, Executive Vice President, Corporate Communications at Acorda. Ma’am, please go ahead. Tierney Saccavino Thank you, [Joana]. Good afternoon, everyone. Before we begin, let me remind you that this presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to refer to those filings. I will now

For further details see:

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2020 Results - Earnings Call Transcript